Doxercalciferol: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Doxercalciferol. Educational only — not medical advice.
Labeled uses
Doxercalciferol capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with CKD on dialysis.
Source: FDA labeling via NIH DailyMed (set 356fb38a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.